MiDye550-Alkyne

MiDye550-Alkyne

Published on 13.02.2012

Properties of the MiDye Chromophore System:

  • Readily applicable to biolabelling, Click 
    conjugation protocols and peptide synthesis
  • Stable under buffer conditions (pH 4-8) 
    and in solid phase peptide synthesis
  • Broadly applied in cell und animal 
    imaging, tested in FRET systems
  • Available in larger quantities compared 
    to e.g. Alexa, Cy-Dyes etc.
  • Purities > 85%, supplied as freeze-dried solid powder

MiDye550-Alkyne – ready for Click Conjugation

Properties of the MiDye Chromophore System:

  • Readily applicable to biolabelling, Click 
    conjugation protocols and peptide synthesis
  • Stable under buffer conditions (pH 4-8) 
    and in solid phase peptide synthesis
  • Broadly applied in cell und animal 
    imaging, tested in FRET systems
  • Available in larger quantities compared 
    to e.g. Alexa, Cy-Dyes etc.
  • Purities > 85%, supplied as freeze-dried solid powder

 

Spectral and other Properties:

  • Absorption 550 nm

  • Emission 580 nm

  • Extinction coefficient 150.000 l/(mol*cm)

  • Quantum Yield 15%


 

MiDye550-Alkyne

C35H42N3NaO7S2, 703,84 g/mole

Code
Quantity Price (EUR)
DYM1040
1mg
5mg
280
950

 

 

Order online

 

Find more dyes from UV to NIR in our section Dyes and Fluorescence Labels.

 

Find more details about MiDye properties and applications in literature:
  • Biocompatible Functionalized Polyglycerol Microgels with Cell Penetrating Properties; Adam L. Sisson, Dirk Steinhilber, Torsten Rossow, Pia Welker, Kai Licha, and Rainer Haag; Angew. Chem. Int. Ed. 2009; 48: 7540 –7545; DOI: 10.1002/anie.200901583.
  • Synthesis, Characterization, and Biological Properties of Cyanine-Labeled Somatostatin Analogues as Receptor-Targeted Fluorescent Probes; Kai Licha, Carsten Hessenius, Andreas Becker, Peter Henklein, Michael Bauer, Stefan Wisniewski, Bertram Wiedenmann, and Wolfhard Semmler; Bioconjugate Chem. 2001;12: 44-50.
  • Optical molecular imaging of lymph nodes using a targeted vascular contrast agent; Kai Licha, Niels Debus, Sonja Emig-Vollmer, Birte Hofmann, Michael Hasbach, Dietger Stibenz, Sabine Sydow, Michael Schirner, Bernd Ebert, Diethard Petzelt, Christoph Bührer, Wolfhard Semmler, Rudolf Tauber; Journal of Biomedical Optics 2005; 10(4): 041205.
  • A complete substitutional analysis of VIP for better tumor imaging properties; Sarah Bhargava, Kai Licha, Tobias Knaute, Bernd Ebert, Andreas Becker, Carsten Grötzinger, Carsten Hessenius, Bertram Wiedenmann, Jens Schneider-Mergener and Rudolf Volkmer-Engert, J. Mol. Recognit. 2002; 15: 145–153; DOI:10.1002/jmr.565.
  • Near-infrared fluorescence imaging with fluorescently labeled albumin: A novel method for non-invasive optical imaging of blood–brain barrier impairment after focal cerebral ischemia in mice; Jan Klohs, Jens Steinbrink, Riad Bourayou, Susanne Mueller, Ryan Cordell, Kai Licha, Michael Schirner, Ulrich Dirnagl, Ute Lindauer, AndreasWunder; Journal of Neuroscience Methods 2009; 180(1): 126-32.
  • Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands; Andreas Becker, Carsten Hessenius, Kai Licha, Bernd Ebert, Uwe Sukowski,Wolfhard Semmler, Bertram Wiedenmann, and Carsten Grötzinger; nature biotechnology 2001; 19: 327-331.